Mouwasat Medical Services Company (TADAWUL:4002)
68.00
-1.25 (-1.81%)
May 4, 2026, 3:19 PM AST
TADAWUL:4002 Cash Flow Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 826 | 822.04 | 645.76 | 657.69 | 599.31 | 578.16 |
Depreciation & Amortization | 240.88 | 240.88 | 234.99 | 220.8 | 186.25 | 155.44 |
Other Amortization | 3.51 | 3.51 | 3 | 2.67 | 2.3 | 2.05 |
Loss (Gain) From Sale of Assets | -1.53 | -1.53 | -1.18 | -0.29 | -0.24 | 0.02 |
Asset Writedown & Restructuring Costs | 0 | 0 | 0 | 0.07 | - | - |
Loss (Gain) From Sale of Investments | - | - | 10.69 | - | - | - |
Loss (Gain) on Equity Investments | - | - | - | -10.21 | -9.88 | -10.45 |
Provision & Write-off of Bad Debts | -9.83 | -9.83 | 78.41 | 117.26 | 18.27 | 5.49 |
Other Operating Activities | 43.39 | 7.27 | -0.78 | 40.48 | 36.24 | 25.02 |
Change in Accounts Receivable | 29.04 | 29.04 | 149.2 | -233.48 | -263.67 | -106.94 |
Change in Inventory | -18.15 | -18.15 | -34.9 | 6.22 | -16.49 | -1.31 |
Change in Accounts Payable | 41.95 | 41.95 | 45.14 | 16.4 | 28.52 | 20.93 |
Change in Other Net Operating Assets | 62.54 | 62.54 | 126.1 | -3.82 | 126.72 | 14.42 |
Operating Cash Flow | 1,218 | 1,178 | 1,256 | 813.78 | 707.33 | 682.83 |
Operating Cash Flow Growth | -4.73% | -6.26% | 54.39% | 15.05% | 3.59% | 42.10% |
Capital Expenditures | -409.63 | -409.63 | -429.02 | -277.04 | -292.81 | -326.94 |
Sale of Property, Plant & Equipment | 2.36 | 2.36 | 1.84 | 0.79 | 0.48 | 5.48 |
Cash Acquisitions | 4.9 | 4.9 | 0.49 | - | -101.65 | - |
Sale (Purchase) of Intangibles | -17.71 | -17.71 | -6.54 | -9.5 | -5.87 | -3.28 |
Investment in Securities | 85 | 85 | 33.49 | 20.85 | -11 | -17 |
Other Investing Activities | -695.46 | -340.56 | -67.76 | -209.81 | -62 | -103.96 |
Investing Cash Flow | -1,031 | -675.64 | -467.5 | -474.7 | -472.85 | -445.71 |
Long-Term Debt Issued | - | 420 | 245 | 180 | 300 | 235 |
Total Debt Issued | 420 | 420 | 245 | 180 | 300 | 235 |
Long-Term Debt Repaid | - | -214.45 | -277 | -279.61 | -238.17 | -191.11 |
Total Debt Repaid | -214.45 | -214.45 | -277 | -279.61 | -238.17 | -191.11 |
Net Debt Issued (Repaid) | 205.55 | 205.55 | -32 | -99.61 | 61.83 | 43.89 |
Common Dividends Paid | -600 | -600 | -350 | -300 | -275 | -250 |
Other Financing Activities | 93.81 | -36.75 | -29.4 | -34.3 | -34.3 | -34.3 |
Financing Cash Flow | -300.64 | -431.2 | -411.4 | -433.91 | -247.47 | -240.41 |
Net Cash Flow | -113.39 | 70.88 | 377.53 | -94.83 | -12.99 | -3.28 |
Free Cash Flow | 808.16 | 768.09 | 827.41 | 536.75 | 414.52 | 355.9 |
Free Cash Flow Growth | -9.28% | -7.17% | 54.15% | 29.49% | 16.47% | 41.90% |
Free Cash Flow Margin | 24.55% | 23.83% | 28.74% | 19.84% | 17.76% | 16.60% |
Free Cash Flow Per Share | 4.04 | 3.84 | 4.14 | 2.68 | 2.07 | 1.78 |
Cash Interest Paid | 51.73 | 51.73 | 48.91 | 50.89 | 28.02 | 17.97 |
Levered Free Cash Flow | - | 458.53 | 602.11 | 263.77 | 160.26 | 133.59 |
Unlevered Free Cash Flow | - | 470.75 | 621.14 | 292.81 | 174.56 | 138.71 |
Change in Working Capital | 115.38 | 115.38 | 285.54 | -214.68 | -124.92 | -72.9 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.